Abstract
Pemphigus is a rare autoimmune blistering disease usually treated with systemic glucocorticoids with adjuvant immunosuppressants or anti-inflammatories. However significant morbidity and mortality is associated with these treatments. This review discusses conventional therapeutic options, as well as new and emerging therapies that may be safer alternatives to broad-based immunosuppression.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 211-224 |
| Number of pages | 14 |
| Journal | Giornale Italiano di Dermatologia e Venereologia |
| Volume | 146 |
| Issue number | 3 |
| State | Published - Jun 2011 |
All Science Journal Classification (ASJC) codes
- Dermatology